Arbutus Biopharma (ABUS) PT Lowered to $6 at H.C. Wainwright

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 6/3/2026

1. PANW
2. SPY
3. ULTA
4. GTLB
5. USO

6. CRWD
7. GOOGL
8. MDT
9. AVGO
10. VRTS

November 10, 2022 6:48 AM EST

Price: $4.35 +2.11%

Rating Summary:
7 Buy, 2 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25

H.C. Wainwright analyst Ed Arce lowered the price target on Arbutus Biopharma (NASDAQ: ABUS) to $6.00 (from $7.50) while maintaining a Buy rating.

Analyst PT Change

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!